tiprankstipranks
Cabaletta Bio announces strategic priorities, anticipated milestones for 2025
PremiumThe FlyCabaletta Bio announces strategic priorities, anticipated milestones for 2025
1M ago
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
Premium
The Fly
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
2M ago
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
2M ago
Cabaletta Bio announces updated clinical data on CABA-201
PremiumThe FlyCabaletta Bio announces updated clinical data on CABA-201
3M ago
Cabaletta Bio’s Promising Clinical Data on CABA-201
Premium
Company Announcements
Cabaletta Bio’s Promising Clinical Data on CABA-201
3M ago
Cabaletta Bio price target lowered to $12 from $20 at Wells Fargo
Premium
The Fly
Cabaletta Bio price target lowered to $12 from $20 at Wells Fargo
3M ago
Cabaletta Bio Outlines Future Trials and Development Strategy
PremiumCompany AnnouncementsCabaletta Bio Outlines Future Trials and Development Strategy
5M ago
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
Premium
The Fly
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
6M ago
Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo
Premium
The Fly
Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100